| NCT Number | NCT07579949 |
| Lead Sponsor | ScinnoHub Pharmaceutical Co., Ltd. |
| Conditions | Thalassemia |
| Enrollment | 30 participants |
| Start Date | 2026-06-18 |
| Primary Completion | 2027-03-29 (estimated) |
| Study Completion | 2027-04-29 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-12 |